RANIBIZUMAB IN PREPROLIFERATIVE (ISCHEMIC) CENTRAL RETINAL VEIN OCCLUSION-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RANIBIZUMAB IN PREPROLIFERATIVE (ISCHEMIC) CENTRAL RETINAL VEIN OCCLUSION

Published:2014-09 Issue:9 Volume:34 Page:1728-1735
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Brown David M.,Wykoff Charles C.,Wong Tien P.,Mariani Angeline F.,Croft Daniel E.,Schuetzle Karri L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference10 articles.

1. . Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase.;Hayreh;Graefes Arch Clin Exp Ophthalmol,1990

2. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion.;Ophthalmology,1995

3. ; CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.;Brown;Ophthalmology,2010

4. . Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.;Campochiaro;Ophthalmology,2011

5. . Vascular endothelial growth factor trap-eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study.;Boyer;Ophthalmology,2012

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oscillatory potential findings in patients with acute ischaemic central retinal vein occlusion;BMJ Open Ophthalmology;2024-08

2. Risk Factors for Developing Neovascular Glaucoma in Central Retinal Vein Occlusion: Two-Year Real-World Study;Ophthalmic Epidemiology;2024-07-31

3. Foveal Thickness Fluctuations in Anti-VEGF Treatment for Central Retinal Vein Occlusion;Ophthalmology Science;2024-03

4. The progress of assessment methods and treatments of neovascular glaucoma secondary to central retinal vein occlusion;Frontiers in Medicine;2024-01-08

5. Vascular endothelial growth factor (VEGF) antagonists for central retinal vein occlusion: an update on clinical progress;Expert Review of Ophthalmology;2023-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3